A New Era in Skincare: Probiotic Serum Achieves 79% Acne Reduction in Clinical Trials
A groundbreaking skincare innovation from New Zealand brand Emma Lewisham has introduced the world’s first probiotic serum containing live Micrococcus luteus – a patented strain discovered on healthy human skin. This pioneering treatment delivers over 350 million live probiotic cells per pump, directly targeting acne-causing bacteria.
Clinical studies have showcased impressive results. When used twice daily, 79% of participants experienced a significant reduction in moderate-to-severe blemishes. “This pioneering serum works by crowding out the bacteria associated with blemishes and acne,” explains founder Emma Lewisham. “It also provides many additional skin health benefits beyond clear skin, including reduced dryness, excess sebum, and redness.”
The breakthrough formula is backed by both in vivo and in vitro clinical studies, representing a major advancement in probiotic skincare technology. The serum addresses multiple skin concerns simultaneously, making it an ideal choice for anyone seeking clearer, healthier skin through microbiome support.
Source: New Beauty
